Cargando…

MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1

BACKGROUND: Studies have suggested that micro‐RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR‐138‐5P (613394) in prostate cancer (PCa) remains unclear. METHODS: Expression level of MIR‐138‐5P in PCa cell lines and normal cell line was analyzed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hui, Xiong, Ying, Wu, Zhensheng, He, Yuhui, Gao, Xianglin, Zhou, Zhangyan, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196466/
https://www.ncbi.nlm.nih.gov/pubmed/32107877
http://dx.doi.org/10.1002/mgg3.1193
_version_ 1783528730979729408
author Huang, Hui
Xiong, Ying
Wu, Zhensheng
He, Yuhui
Gao, Xianglin
Zhou, Zhangyan
Wang, Tao
author_facet Huang, Hui
Xiong, Ying
Wu, Zhensheng
He, Yuhui
Gao, Xianglin
Zhou, Zhangyan
Wang, Tao
author_sort Huang, Hui
collection PubMed
description BACKGROUND: Studies have suggested that micro‐RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR‐138‐5P (613394) in prostate cancer (PCa) remains unclear. METHODS: Expression level of MIR‐138‐5P in PCa cell lines and normal cell line was analyzed with the quantitative real‐time PCR method. Cell counting kit‐8 assay, colony formation assay, wound‐healing assay, and transwell invasion assay were performed to analyze the biological functions of MIR‐138‐5P. RESULTS: We showed MIR‐138‐5P expression level was significantly decreased in PCa cell lines compared with the normal cell line. Overexpression of MIR‐138‐5P inhibits PCa cell proliferation, colony formation, cell migration, and cell invasion in vitro. Mechanistically, we showed Forkhead box C1 (FOXC1, 601090) was a direct target for MIR‐138‐5P in PCa. We confirmed that overexpression of FOXC1 partially reversed the effects of MIR‐138‐5P on PCa cell behaviors. CONCLUSIONS: Collectively, we showed that MIR‐138‐5P functions as a tumor suppressor gene in PCa via targeting FOXC1.
format Online
Article
Text
id pubmed-7196466
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71964662020-05-04 MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1 Huang, Hui Xiong, Ying Wu, Zhensheng He, Yuhui Gao, Xianglin Zhou, Zhangyan Wang, Tao Mol Genet Genomic Med Original Articles BACKGROUND: Studies have suggested that micro‐RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR‐138‐5P (613394) in prostate cancer (PCa) remains unclear. METHODS: Expression level of MIR‐138‐5P in PCa cell lines and normal cell line was analyzed with the quantitative real‐time PCR method. Cell counting kit‐8 assay, colony formation assay, wound‐healing assay, and transwell invasion assay were performed to analyze the biological functions of MIR‐138‐5P. RESULTS: We showed MIR‐138‐5P expression level was significantly decreased in PCa cell lines compared with the normal cell line. Overexpression of MIR‐138‐5P inhibits PCa cell proliferation, colony formation, cell migration, and cell invasion in vitro. Mechanistically, we showed Forkhead box C1 (FOXC1, 601090) was a direct target for MIR‐138‐5P in PCa. We confirmed that overexpression of FOXC1 partially reversed the effects of MIR‐138‐5P on PCa cell behaviors. CONCLUSIONS: Collectively, we showed that MIR‐138‐5P functions as a tumor suppressor gene in PCa via targeting FOXC1. John Wiley and Sons Inc. 2020-02-28 /pmc/articles/PMC7196466/ /pubmed/32107877 http://dx.doi.org/10.1002/mgg3.1193 Text en © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Huang, Hui
Xiong, Ying
Wu, Zhensheng
He, Yuhui
Gao, Xianglin
Zhou, Zhangyan
Wang, Tao
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
title MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
title_full MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
title_fullStr MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
title_full_unstemmed MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
title_short MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
title_sort mir‐138‐5p inhibits the progression of prostate cancer by targeting foxc1
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196466/
https://www.ncbi.nlm.nih.gov/pubmed/32107877
http://dx.doi.org/10.1002/mgg3.1193
work_keys_str_mv AT huanghui mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1
AT xiongying mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1
AT wuzhensheng mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1
AT heyuhui mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1
AT gaoxianglin mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1
AT zhouzhangyan mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1
AT wangtao mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1